Die Dai
Impact in
-
- Gut microbiota and health
- Genomics and Phylogenetic Studies
- Metabolomics and Mass Spectrometry Studies
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Gut microbiota and health 10
- Metabolomics and Mass Spectrometry Studies 3
- Oncology 4
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Sicheng Wu (3 shared papers)Kang Ning (2 shared papers)Chuqing Sun (2 shared papers)Xing‐Ming Zhao (2 shared papers)Lijie He (2 shared papers)Min Li (1 shared paper)Jinxin Liu (1 shared paper)Teng Wang (2 shared papers)
In The Last Decade
Die Dai
15 papers receiving 580 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 341
- Infectious Diseases 74
- Gastroenterology 25
- Oncology 66
- Biological Psychiatry 3
Countries citing papers authored by Die Dai
This map shows the geographic impact of Die Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Die Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Die Dai more than expected).
Fields of papers citing papers by Die Dai
This network shows the impact of papers produced by Die Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Die Dai. The network helps show where Die Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Die Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 131 | |
| 2 | 2019 | 117 | |
| 3 | 2020 | 117 | |
| 4 | 2023 | 48 | |
| 5 | 2023 | 32 | |
| 6 | 2023 | 27 | |
| 7 | 2024 | 24 | |
| 8 | 2016 | 22 | |
| 9 | 2015 | 19 | |
| 10 | 2019 | 18 | |
| 11 | 2022 | 18 | |
| 12 | 2020 | 7 | |
| 13 | 2026 | 5 | |
| 14 | 2025 | 2 | |
| 15 | 2025 | 1 | |
| 16 | 2026 | 0 | |
| 17 | 2026 | 0 |
About Die Dai
Die Dai is a scholar working on Molecular Biology, Oncology, Surgery, Gastroenterology and Obstetrics and Gynecology, having authored 17 papers that have together received 588 indexed citations. Recurring topics across this work include Gut microbiota and health (10 papers), Cancer Immunotherapy and Biomarkers (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Sepsis Diagnosis and Treatment (2 papers), Abdominal vascular conditions and treatments (2 papers), COVID-19 Clinical Research Studies (1 paper), Cancer Genomics and Diagnostics (1 paper) and Gastrointestinal motility and disorders (1 paper). The work is most often cited by research in Molecular Biology (341 citations), Infectious Diseases (74 citations), Gastroenterology (25 citations), Oncology (66 citations) and Biological Psychiatry (3 citations). Die Dai has collaborated with scholars based in China, Germany and Macao. Frequent co-authors include Sicheng Wu, Kang Ning, Chuqing Sun, Xing‐Ming Zhao, Lijie He, Min Li, Jinxin Liu, Teng Wang, Na Gao and Fengguo Xu. Their work appears in journals such as Nucleic Acids Research, Frontiers in Microbiology, Cell Reports Medicine, Food & Function and Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.